The ESMO Immuno-Oncology 2021 programme is now online!
- Update your knowledge on the fast-developing field of cancer immunotherapy and related biomarkers
- Understand what is in progress on immune modulation beyond checkpoint inhibition, focusing on tumour microenvironment, cellular-based approaches, genetic T-cell engineering and microbiome.
- Review state-of-the-art diagnostic, biomarker and therapeutic strategies in immune-oncology, applicable to the most frequent cancers
- Be informed on emerging evidence and research on immunotherapies in combination with other anti-cancer targeted therapies
ESMO-MORA: The ESMO Immuno-Oncology 2021 programme has been accredited with 19 Cat. 1 ESMO-MORA points. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. It also guarantees that a certified medical oncologist has continued to update her/his knowledge and still possess the necessary skills and standards for the practice of medical oncology. See here for further details.
The congress webcasts will include all the sessions of the official programme, where speaker permission is granted, and will be available on this website and on OncologyPRO for ESMO members.